RTCure

RTCure - Rheuma Tolerance for Cure is an EU/IMI2-funded research project aiming to develop new therapies for rheumatoid arthritis by inducing immune tolerance.

[Innovative Health Initiative @IHIEurope]

🤔If #arthritis was detected earlier, could it be prevented? The @RTCure_eu project sought to understand just that! Join us on 5 June at 11:00 for 'In conversation with RT Cure' where we'll find out about their work on #ArthritisResearch. Register here: https://t.co/ZiJveZy9kH

[PREFER: patient preferences @IMI_PREFER]

Preferences for preventive treatments for #rheumatoidarthritis: discrete choice survey in the UK, Germany and Romania 👇

https://t.co/eZxKCZXbF8

[Digital Rheumatology Network @digital_rheuma]

We are pleased to invite you to the 5th Digital rheumatology day. Register today!

https://t.co/6dTzClXSe0

[Dr Marie Falahee @DrMarieFalahee]

NEW PAPER: What risk of side effects is acceptable for a reduced risk of developing rheumatoid arthritis? Informing patient-focussed drug development

https://t.co/oVQhNA1mlk

@IMI_PREFER @RRG_Birmingham @InflamAge_UoB @NIHRBhamBRC @BHPComms @unibirm_MDS

[Digital Rheumatology Network @digital_rheuma]

Apply now for the "Digital Rheumatology Research Award"!
Please find further information on how to apply here:
https://t.co/QjLjg1iIon
#RheumaAward #DigitalRheumatology

[CRA SCR @CRASCRRheum]

🔔State-of-the-Art Keynote Speaker

Meet Dr. @ProfJohnIsaacs, our State-of-the-Art keynote speaker at the 2023 Annual Scientific Meeting!

He will be delivering a keynote presentation on Precision Medicine in Rheumatoid Arthritis.

Register today🔗https://t.co/1pGqGUT8j3

[Rheumatoid Patient @rheumpatient]

Our latest paper on patient and public involvement (#PPI) in @RTCure_eu. #rheumatology https://t.co/ZrjUoRWFXD

[Paul Studenic @Stiddyo]

@ArthritisDigest @Arthritisie @VersusArthritis @K_Betteridge @Neil_Betteridge @Kouloumasm @xico_nunes @humanaic @NRAS_UK @SjogrenEurope @RTCure_eu @orf_at @H12R12 @ArthritisDay @RA_information @DtRheumaLiga @puls4

[RTCure @RTCure_eu]

@rheumpatient Congratulations on Twitter as well!

[PREFER: patient preferences @IMI_PREFER]

JUST PUBLISHED: Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis by G Simons, K Schölin Bywall, M Englbrecht, EC Johansson, RL Disantostefano, C Radawski @JorienVeldwijk K Raza & @DrMarieFalahee 👇
https://t.co/uhZBt0uTFN

[dennis lendrem @dennislendrem]

Interesting genetic analysis by Rachel Knevel on drug-free remission from @RTCure_eu #TTW2022 A smoking gun analysis implicates the fibroblast?

[Maximilian Kugler @MaxKugler_]

Great Pleasure to present my PhD project to partners from industry & academia @RTCure_eu Annual Meeting 2022 in Amsterdam.

[dennis lendrem @dennislendrem]

Great presentations this afternoon on early trials in ACPA positive and the progression to RA @MRGNewcastle @Racegbn @RTCure_eu

[MRG Newcastle @MRGNewcastle]

A landmark paper. RA-MAP Scientific Data - the most complete immunological profile in early rheumatoid arthritis to date
@RTCure_eu @Racegbn @ProfJohnIsaacs @thebarneslab @imidbio

https://t.co/R97BAJnbWA

[Johannes Knitza @JK77775]

Accelerating diagnosis in #rheumatology using #ehealth📲🚀😀 Great #teamwork @ArndKlyr @Dr_David_Simon led by @RachelKnevel supported by @EITHealth https://t.co/5E2h4cGvsa @digital_rheuma @medizin_digital

[PREFER: patient preferences @IMI_PREFER]

Want to know more about quantitative preference studies of treatments for #RheumatoidArthritis among #patients and at-risk populations? @IMI_PREFER published a #SystematicReview!

#RA @reumatiker @R2P2_UoB @InflamAge_UoB 👇

https://t.co/WwkgTDTyRd

[RACE GBN @Racegbn]

At #BSR22 3pm you may like to attend the 'Prediction and prevention of rheumatoid arthritis: an update' session chaired by RACE's Karim Raza with talks from John Isaacs and Marie Falahee amongst others (venue Boisdale) @ProfJohnIsaacs @DrMarieFalahee @MRGNewcastle @RRG_Birmingham

[Paul Studenic @Stiddyo]

Increasingly more programs for individuals #at-risk for #rheumatoid #arthritis exist across Europe. With @RTCure_eu we have built the framework for researching together by setting up the #European Risk RA registry
https://t.co/jqmet7K8p9
🎞️a summary: https://t.co/JSFZOMqKel

[Digital Rheumatology Network @digital_rheuma]

Join our event either virtually or on site in Berlin from May 6-7 and explore the future in Rheumatology! Register today: https://t.co/CFZBsE7gbn #DigitalRheumatologyDay @LatikaGupta_ @JK77775 @KruscheMartin @ThomasHugle @Dr_David_Simon

[MRG Newcastle @MRGNewcastle]

@RTCure_eu @Racegbn Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis https://t.co/I4CHIevQK3